Continued strong Cresemba® (isavuconazole) sales trigger milestone from Pfizer to Basilea of USD 10 million

NEXT STORY
Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved in South Korea
PREV STORY
Innate Pharma advances lacutamab clinical development program
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Caring in a Digital World: 9th Annual E-Mental Health Conference keeps pace with rapidly changing mental health technology

author_avatar
NASDAQ Market News

Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS)

– Single Agent Ivosidenib Demonstrated CR+CRh Rate of 42.4% and Overall Response Rate (ORR) ...

author_avatar
NASDAQ Market News

BioFit Reviews: What We Found May Shock You! Probiotic Pills Update by Researched Reviews

author_avatar
NASDAQ Market News